Author: Olli Moisio

Riikka will defend her thesis titled “Evaluation of 68Ga-labeled PET radiopharmaceuticals for imaging of avß3 integrin and vascular adhesion protein-1 in inflammation and cancer”. Her thesis can be found in the University of Turku Annales: http://urn.fi/URN:ISBN:978-951-29-8360-5.

The public event will be held Friday February 19th 2021 at 12 o’clock as an online defence. D.Med.Sc Johanna Huhtakangas (Kuopio University Hospital) will act as the opponent and professor Anne Roivainen as the custodian. The defence is in Finnish.

More info (Finnish): https://www.utu.fi/fi/ajankohtaista/tapahtumat/vaitos-kliininen-fysiologia-ja-isotooppilaaketiede-fm-riikka-viitanen

Mia will defend her thesis titled “Molecular imaging and immunotherapy in atherosclerotic cardiovascular disease”. Her thesis can be found in the University of Turku Annales: http://urn.fi/URN:ISBN:978-951-29-8258-5.

The public event will be held Saturday November 28th 2020 at 12 o’clock in the Risto Lahesmaa – lecture hall (TYSK T-Hospital, Hämeenkatu 11, Turku). Professor Risto Kerkelä (University of Oulu) will act as the opponent and professor Juhani Knuuti as the custodian. The defence is in Finnish.

The event can be observed online trough this link: https://utu.zoom.us/j/63740713455?pwd=elh5RG83V3RXbkZTUDNtNnVTcE4xZz09.

Petri will defend his thesis titled “Preclinical evaluation of novel radiopharmaceuticals for positron emission tomography imaging of animal models of multiple sclerosis”. His thesis can be found in the University of Turku Annales: http://urn.fi/URN:ISBN:978-951-29-8182-3.

The public event will be held Friday November 6th 2020 at 12 o’clock in the Johan Haartman – lecture hall (TYSK T-Hospital, Hämeenkatu 11, Turku). Professor Andrea Varrone (Karolinska instutet, Sweden) will act as the opponent and professor Anne Roivainen as the custodian.

You can follow the defence online at https://utu.zoom.us/j/64592782155?pwd=aDk0Wlovai9LVGY1WFhIV0FOSXBpdz09.

Maria will defend her thesis titled “PET imaging of ischaemic myocardial injury and angiogenesis”. Her thesis can be found in the University of Turku Annales: http://urn.fi/URN:ISBN:978-951-29-8157-1.

The public event will be held Friday October 9th 2020 at 12 o’clock in the Risto Lahesmaa – lecture hall (TYSK T-Hospital, Hämeenkatu 11, Turku). Professor Tomi Laitinen (University of Eastern Finland) will act as the opponent and professor Antti Saraste as the custodian. The defence is in Finnish.

The event can be observed online trough this link: https://recorder.uc.2m-it.fi/streamit/lahesmaa.html.

A member of our group has received an award!

Riikka Viitanen, a PhD student at Turku PET Centre and Drug Research Doctoral Programme of University of Turku Graduate School, has been awarded the annual Alavi-Mandell Award from the Society of Nuclear Medicine and Molecular Imaging for her publication in the Journal of Nuclear Medicine. She is the first author of paper entitled with “⁶⁸Ga-DOTA-E[c(RGDfK)]₂ Positron Emission Tomography Imaging of SHARPIN-Regulated Integrin Activity in Mice”.

 

http://jnm.snmjournals.org/content/60/10/1380.long

Alavi-Mandell Award is given to individuals who were the first author of a paper published in the Journal of Nuclear Medicine that were trainees at the time the published work was carried out and made a major contribution to the completion of the work. The Alavi-Mandell Award aims to encourage the young scientists to pursue a career in academic and research in nuclear medicine.

Meeri will defend her thesis titled “Gallium-68 radiolabeling of biomolecules for positron emission tomography with special reference to imaging of inflammation and bone”.

The public event will be held Saturday February 29th 2020 at 12 o’clock in the Lauren 2 lecture hall (Medisiina D, Kiinamyllynkatu 10). Associate Professor (VU University Amsterdam) will act as the opponent and professor Anne Roivainen as the custodian. The dissertation is in English.

 

Max will publicly defend his PhD thesis “Molecular Imaging of Tissue Repair after Myocardial Infarction, Preclinical evaluation of novel (68)Ga-labeled PET tracers”.

The public event will be held Friday June 1st 2018 at 12 o’clock in the Risto Lahesmaa lecture hall (TYKS, T -hospital, Hämeentie 11). Professor John Prior (University of Lausanne) will act as the opponent and associate professor Antti Saraste (University of Turku) as the custodian. The dissertation is in English.

Roivainen group is a part of the Health from Science programme (TERVA) of the Academy of Finland. The programme spans from 2018 to 2020.

Our project in the programme is Reprogramming of macrophage phenotypes as early predictor of cardiovascular and metabolic disease development (MAP-CAD). One of our postdocs, Senthil Palani, is already working hard on the project.

Funding decicions for the TERVA programme were made november 2017.

Link to TERVA programme Homepage.